Atwater Malick’s Corteva CTVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$294K Sell
3,787
-4
-0.1% -$331 0.06% 103
2026
Q2
$321K Buy
3,791
+487
+15% +$39.1K 0.07% 96
2026
Q1
$277K Hold
3,304
– – 0.07% 81
2025
Q4
$221K Hold
3,304
– – 0.06% 83
2025
Q3
$223K Hold
3,304
– – 0.06% 78
2025
Q2
$246K Hold
3,304
– – 0.08% 75
2025
Q1
$208K Buy
+3,304
New +$204K 0.07% 75
2022
Q2
– Sell
-3,729
Closed -$214K – 55
2022
Q1
$214K Buy
+3,729
New +$191K 0.1% 55
2019
Q4
– Sell
-3,857
Closed -$108K – 79
2019
Q3
$108K Buy
+3,857
New +$112K 0.09% 48

Other funds holding CTVA

Atwater Malick's CTVA Position: Q3 2026 in Review

Atwater Malick reduced its Corteva (CTVA) stake by 0.11% in Q3 2026, selling an estimated $331 and leaving 3,787 shares worth $294K. The position accounts for 0.06% of the portfolio, ranked #103.

Atwater Malick first reported a position in CTVA in Q3 2019 and has held it in 9 quarters since. The position peaked at $321K in Q2 2026. 512 funds tracked by Wall St. Rank hold CTVA as of Q3 2026.

  • Atwater Malick held 3,787 shares of Corteva worth $294K as of Q3 2026.
  • Atwater Malick sold 4 Corteva shares in Q3 2026, an estimated $331.
  • Corteva made up 0.06% of Atwater Malick's portfolio in Q3 2026, its #103 holding.
  • Atwater Malick first reported a position in Corteva in Q3 2019 and has held it in 9 quarters since.
  • Atwater Malick's Corteva position peaked at $321K in Q2 2026.
  • 512 funds tracked by Wall St. Rank held Corteva as of Q3 2026.

Based on Atwater Malick's 13F filing for Q3 2026, filed 15 Oct 2026.